Clinical Trials Browser

Interventional × Metastatic Castration-resistant Prostate Cancer (mCRPC) × 90 days × Clear all

NCT07310355 2025-12-30

68Ga-PSMA-0057 and 177Lu-PSMA-0057 in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer

Phase 1/2 Not yet recruiting

Metastatic Castration-resistant Prostate Cancer (mCRPC)